Alternatives to Invyncible

Unusually complete disclosure for a compounded seller: four dispensing pharmacies named outright with links and phone numbers, OpenLoop named as the prescribing partner, and genuine brand access to Wegovy, Zepbound and Ozempic alongside the compounded line. Compounded GLP-1 injections start at $179 a month and daily dissolvable tablets at $249. The price follows the form, not the molecule — the product page never names semaglutide or tirzepatide, and the terms confirm both are in scope, so either molecule costs the same. Two caveats matter for planning. The brand products are quoted as a membership plus a medication cost that is never published, and the membership appears at two different figures on one page: $99 beside Zepbound and Wegovy, $171 beside Ozempic. And the terms provide that a provider may switch your molecule, with continued enrollment counted as consent and charges continuing. It also discloses that people in its advertising may be actors or artificial intelligence rather than clinicians. No time to first dose is published.

Pallas Health removes the two things that usually cost a working parent the most time: it publishes every price before intake, and it runs care asynchronously in 43 of 50 states, so there's no video appointment to wedge into a workday. Compounded semaglutide averages about $199 a month and tirzepatide $299, and unusually the genuine FDA-approved pens sit alongside them — Zepbound $1,069, Ozempic $1,299, Wegovy and Mounjaro $1,349 — all cash-pay from the same clinician. The price is flat at every dose, so a titration never produces a surprise bill, and the plan figure already contains the clinician, dose adjustments, check-ins and messaging with no membership fee. Its cancellation terms are unusually concrete: cancel free through the portal, keep access to the end of the paid period, full refund if a clinician declines you, and a $5 processing fee on a qualifying refund. The trade-offs are that billing lands every 12 weeks in $597 and $897 blocks rather than monthly, the compounding pharmacy is never named, and insurance is never billed.

$147/mo semaglutide, $249/mo tirzepatide, an oral tablet option, brand-name Wegovy/Zepbound on the same menu, and 49-state coverage — the best state reach here, undercut by a cancellation policy that isn't published anywhere.

Compounded semaglutide at $199 a month and tirzepatide at $299, the same price at every dose, and the daily tablet costs the same as the injection on both — all of it on an open pricing page you reach without a quiz. Brand-name prices are published too, which is rare: Wegovy $999, Ozempic $899, Mounjaro $999, cash. Two things to know before you enter a card. The badge at the top of every page says no subscription, and its own FAQ then asks whether you can cancel your subscription and tells you to call before your next billing date — so it does recur, whatever the badge says. And nothing anywhere on the site says how many weeks of medication one $199 charge actually buys. It ships to all 50 states, and it carries a June 2026 FDA warning letter for false or misleading claims, which it has since fixed.

The widest menu on the board — compounded, oral and four brand pens, all on a chat visit with no camera — sold behind a pricing page that quotes you a monthly figure for a plan you have to pay for a year in advance.

A rare compounded-plus-brand shop with five real price points disclosed up front — $179/mo compounded semaglutide up to $1,086/mo brand Zepbound — though the oral tablet's exact molecule split isn't fully clear.

Compounded semaglutide from $149 a month and tirzepatide from $199, with a genuine microdose line at $129 and a dissolving oral tablet at $169 — a wider catalog than most, and it includes hormone therapy for women from $69. The number to ignore is the one it leads with. 'Starting at $99/mo' runs across every page, and no GLP-1 on the site costs $99: the cheapest is the $129 microdose. The $99 belongs to its NAD+ nasal spray. Two more gaps worth knowing. Every price is a floor, with no ongoing rate published. And it names no company anywhere — no LLC, no address, nothing in the terms or privacy policy.

$114 is the lowest semaglutide figure on this page, and it comes with a condition SurpassMD prints only in its FAQ: the price applies "for eligible patients with a promotion". The standing rate is published nowhere, which makes budgeting past the first cycle guesswork. What is solid: all fifty states plus DC, 503A compounding, cold-chain shipping within 48 hours of approval, HSA and FSA accepted, cancel anytime. There is an oral semaglutide as well, with no price attached.

The complete ladder is on the page before any intake, which almost nothing else here does: semaglutide $199 a month, $549 for three months, $999 for six, $1,788 for twelve; tirzepatide $299, $797, $1,494, $2,748. Read the long tiers correctly — each is a single upfront charge rather than a smaller monthly bill, so the advertised $149 means paying a full year before the first box ships. Disclosure is above average where it counts. Andrew Meds LLC is named with a Houston address, and the practice that writes the prescription is named separately as Dr Tel X in Kennewick, Washington. Coverage is all fifty states and DC, enumerated rather than claimed, and there is an oral tirzepatide alongside the injections. The gaps: the compounding pharmacy is never named, no time to first dose is published, and a period you have partly used is not refunded.